BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 20591528)

  • 1. Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice.
    Vanwolleghem T; Libbrecht L; Hansen BE; Desombere I; Roskams T; Meuleman P; Leroux-Roels G
    J Hepatol; 2010 Sep; 53(3):468-76. PubMed ID: 20591528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections.
    Kosaka K; Hiraga N; Imamura M; Yoshimi S; Murakami E; Nakahara T; Honda Y; Ono A; Kawaoka T; Tsuge M; Abe H; Hayes CN; Miki D; Aikata H; Ochi H; Ishida Y; Tateno C; Yoshizato K; Sasaki T; Chayama K
    Biochem Biophys Res Commun; 2013 Nov; 441(1):230-5. PubMed ID: 24140055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host and viral determinants for engraftment of virus permissive human hepatocytes into chimeric immunodeficient mice.
    Robinet E; Baumert TF
    J Hepatol; 2010 Sep; 53(3):421-3. PubMed ID: 20561706
    [No Abstract]   [Full Text] [Related]  

  • 4. Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection.
    Meuleman P; Steyaert S; Libbrecht L; Couvent S; Van Houtte F; Clinckspoor F; de Hemptinne B; Roskams T; Vanlandschoot P; Leroux-Roels G
    Clin Chim Acta; 2006 Apr; 366(1-2):156-62. PubMed ID: 16253217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.
    Meuleman P; Libbrecht L; De Vos R; de Hemptinne B; Gevaert K; Vandekerckhove J; Roskams T; Leroux-Roels G
    Hepatology; 2005 Apr; 41(4):847-56. PubMed ID: 15791625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal model for study of human hepatitis viruses.
    Chayama K; Hayes CN; Hiraga N; Abe H; Tsuge M; Imamura M
    J Gastroenterol Hepatol; 2011 Jan; 26(1):13-8. PubMed ID: 21175788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric mouse model for the infection of hepatitis B and C viruses.
    Tesfaye A; Stift J; Maric D; Cui Q; Dienes HP; Feinstone SM
    PLoS One; 2013; 8(10):e77298. PubMed ID: 24155939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of humanized mice for the study of hepatitis C virus infection.
    Turrini P; Sasso R; Germoni S; Marcucci I; Celluci A; Di Marco A; Marra E; Paonessa G; Eutropi A; Laufer R; Migliaccio G; Padron J
    Transplant Proc; 2006 May; 38(4):1181-4. PubMed ID: 16757300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-rapid cardiotoxicity of the hepatitis C virus protease inhibitor BILN 2061 in the urokinase-type plasminogen activator mouse.
    Vanwolleghem T; Meuleman P; Libbrecht L; Roskams T; De Vos R; Leroux-Roels G
    Gastroenterology; 2007 Oct; 133(4):1144-55. PubMed ID: 17919490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.
    Meuleman P; Leroux-Roels G
    Antiviral Res; 2008 Dec; 80(3):231-8. PubMed ID: 18706933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology.
    Uchida T; Imamura M; Kan H; Hiraga N; Hayes CN; Tsuge M; Abe-Chayama H; Aikata H; Makokha GN; Miki D; Ochi H; Ishida Y; Tateno C; Chayama K
    J Gen Virol; 2017 May; 98(5):1040-1047. PubMed ID: 28141486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein profiles in SCID/uPA mice transplanted with human hepatocytes become human-like and correlate with HCV infection success.
    Steenbergen RH; Joyce MA; Lund G; Lewis J; Chen R; Barsby N; Douglas D; Zhu LF; Tyrrell DL; Kneteman NM
    Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G844-54. PubMed ID: 20651006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes.
    Tabuchi A; Tanaka J; Katayama K; Mizui M; Matsukura H; Yugi H; Shimada T; Miyakawa Y; Yoshizawa H
    J Med Virol; 2008 Dec; 80(12):2064-8. PubMed ID: 19040280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus.
    Dandri M; Burda MR; Török E; Pollok JM; Iwanska A; Sommer G; Rogiers X; Rogler CE; Gupta S; Will H; Greten H; Petersen J
    Hepatology; 2001 Apr; 33(4):981-8. PubMed ID: 11283864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
    Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
    Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of natural killer cells in the rejection of human hepatocytes after xenotransplantation into immunodeficient mice.
    Kawahara T; Douglas DN; Lewis J; Lund G; Addison W; Tyrrell DL; Churchill TA; Kneteman NM
    Transpl Int; 2010 Sep; 23(9):934-43. PubMed ID: 20180929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes.
    Dandri M; Burda MR; Zuckerman DM; Wursthorn K; Matschl U; Pollok JM; Rogiers X; Gocht A; Köck J; Blum HE; von Weizsäcker F; Petersen J
    J Hepatol; 2005 Jan; 42(1):54-60. PubMed ID: 15629507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
    Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
    Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human hepatocyte propagation system in the mouse livers: functional maintenance of the production of coagulation and anticoagulation factors.
    Tatsumi K; Ohashi K; Tateno C; Yoshizato K; Yoshioka A; Shima M; Okano T
    Cell Transplant; 2012; 21(2-3):437-45. PubMed ID: 22793051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation.
    Dandri M; Burda MR; Gocht A; Török E; Pollok JM; Rogler CE; Will H; Petersen J
    Hepatology; 2001 Oct; 34(4 Pt 1):824-33. PubMed ID: 11584382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.